Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan J Keam

Showing results (1-10 of 215) with videos related to

Pageof 22
Sort By:
Molecular Diagnosis & Therapy|August 23, 2021
Elivaldogene Autotemcel: First ApprovalSusan J Keam
Drugs|December 23, 2024
Arimoclomol: First ApprovalSusan J Keam
Drugs|December 26, 2022
Tremelimumab: First ApprovalSusan J Keam
Molecular Diagnosis & Therapy|July 22, 2021
Piflufolastat F 18: Diagnostic First ApprovalSusan J Keam
Drugs|May 31, 2022
Olipudase Alfa: First ApprovalSusan J Keam
Drugs|September 10, 2008
Doripenem: a review of its use in the treatment of bacterial infectionsSusan J Keam
Drugs|November 26, 2023
Iruplinalkib: First ApprovalSusan J Keam
Drugs|August 8, 2022
Tapinarof Cream 1%: First ApprovalSusan J Keam
Drugs|August 23, 2022
Linzagolix: First ApprovalSusan J Keam
Drugs|September 25, 2025
Famitinib: First ApprovalSusan J Keam
Pageof 22

Showing results (1-10 of 215) with videos related to

Sort By:
Pageof 22
Molecular Diagnosis & Therapy|August 23, 2021
Elivaldogene Autotemcel: First ApprovalSusan J Keam
Drugs|December 23, 2024
Arimoclomol: First ApprovalSusan J Keam
Drugs|December 26, 2022
Tremelimumab: First ApprovalSusan J Keam
Molecular Diagnosis & Therapy|July 22, 2021
Piflufolastat F 18: Diagnostic First ApprovalSusan J Keam
Drugs|May 31, 2022
Olipudase Alfa: First ApprovalSusan J Keam
Drugs|September 10, 2008
Doripenem: a review of its use in the treatment of bacterial infectionsSusan J Keam
Drugs|November 26, 2023
Iruplinalkib: First ApprovalSusan J Keam
Drugs|August 8, 2022
Tapinarof Cream 1%: First ApprovalSusan J Keam
Drugs|August 23, 2022
Linzagolix: First ApprovalSusan J Keam
Drugs|September 25, 2025
Famitinib: First ApprovalSusan J Keam
Pageof 22